Biotech Co.*

Pharma Co.


Terms/Details (Date)

Bioenvision Inc. (OTC BB: BIOV)

Penn Pharmaceutical Services Ltd. (UK)


Penn Pharmaceutical will label, package, store and distribute clofarabine in Europe (5/15)

BioTime Inc. (AMEX:BTX)

CJ Corp. (South Korea)

Hextend and PentaLyte blood plasma volume expanders

Exclusive licensing agreement for CJ to manufacture and sell the expanders in South Korea for human therapeutic uses; CJ will be responsible for obtaining regu- latory approvals and will bear all related costs and expenses (4/14)

Celgene Corp. (CELG)

GlaxoSmithKline plc (UK)


Celgene will buy Alkeran tablets and Alkeran for injection from GSK and then distribute the product under Celgene's label; financial details were not disclosed (4/14)

Eyetech Pharmaceuticals Inc.*

Pfizer Inc.


Eyetech will participate in U.S. sales of Xalatan, a glaucoma medication (4/22)

Labopharm Inc. (Canada; TSE:DDS)

Gruppo Angelini (Italy) and Esteve SA (Spain)

A once-daily version of the analgesic tramadol

Gruppo Angelini will market the product in Italy, and Esteve will market it in Spain and Portugal (4/22)

TolerRx Inc.*

Laureate Pharma LP

Monoclonal antibodies

Manufacturing and services agreement regarding monoclonal antibodies from Toler-Rx under which it will provide purification and aseptic filling services to support TolerRx's clinical trials (3/26)

United Therapeutics Corp. (UTHR)

Caremark Inc.


Caremark will distribute Remodulin in the U.S. for the treatment of pulmonary arterial hypertension (5/20)


# The information in the chart does not cover agricultural agreements or those between biotech companies.

* Private companies are indicated with an asterisk.

Unless otherwise noted, stock symbols listed are on the Nasdaq market.

AMEX = American Stock Exchange; OTC BB = Over-the-Counter Bulletin Board; TSE = Toronto Stock Exchange